James McCord

Dr. James McCord

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2001 in Circulation
Verified
Journal Article
Closed access
PDF file
JMJames McCord
James McCord
RNRichard M. Nowak
Richard M. Nowak
PMPeter A. McCullough
Peter A. McCullough
CFCraig Foreback
Craig Foreback
SBSteven Borzak
Steven Borzak
WWW. Douglas Weaver
W. Douglas Weaver
Background Diagnostic strategies with ECG and serum cardiac markers have been used to rule out acute myocardial infarction in 6 to 12 hours. The present study evaluated whether a multimarker strategy that used point-of-care measurement of myoglobin, creatine kinase (CK)-MB, and troponin I could exclude acute myocardial infarction in ≤3 hours. Methods and Results We prospectively enrolled consecutive patients (n=817) in the emergency department who were evaluated for possible acute myocardial infarction. In patients with nondiagnostic ECGs, we measured CK-MB, troponin I, and myoglobin with a point-of-care device at presentation and at 90 minutes, 3 hours, and 9 hours. Standard central laboratory testing of CK-MB was done at the same time intervals, and triage decisions were made by emergency physicians who were unaware of point-of-care results. Sensitivity and negative predictive value were compared for both the multimarker, point-of-care approach and the central laboratory strategy. Sensitivity and negative predictive value for point-of-care combination of myoglobin and troponin I by 90 minutes was 96.9% and 99.6%, respectively. CK-MB measurements and blood sampling at 3 hours did not improve sensitivity or negative predictive value. Median time from sampling to reporting of results was 71.0 minutes for the central laboratory versus 24.0 minutes for the point-of-care device ( P <0.001). Conclusions Acute myocardial infarction can be excluded rapidly in the emergency department by use of point-of-care measurements of myoglobin and troponin I during the first 90 minutes after presentation.

1 February 2017 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
JMJames McCord
James McCord
RCRafael Cabrera
Rafael Cabrera
BLBertil Lindahl
Bertil Lindahl
EGEvangelos Giannitsis
Evangelos Giannitsis
KEKaleigh Evans
Kaleigh Evans
CZChristian Zaugg
Christian Zaugg
Background—: The TRAPID-AMI trial study (High-Sensitivity Troponin-T Assay for Rapid Rule-Out of Acute Myocardial Infarction) evaluated high-sensitivity cardiac troponin-T (hs-cTnT) in a 1-hour acute myocardial infarction (AMI) exclusion algorithm. Our study objective was to evaluate the prognostic utility of a modified HEART score (m-HS) within this trial. Methods and Results—: Twelve centers evaluated 1282 patients in the emergency department for possible AMI from 2011 to 2013. Measurements of hs-cTnT (99th percentile, 14 ng/L) were performed at 0, 1, 2, and 4 to 14 hours. Evaluation for major adverse cardiac events (MACEs) occurred at 30 days (death or AMI). Low-risk patients had an m-HS≤3 and had either hs-cTnT<14 ng/L over serial testing or had AMI excluded by the 1-hour protocol. By the 1-hour protocol, 777 (60%) patients had an AMI excluded. Of those 777 patients, 515 (66.3%) patients had an m-HS≤3, with 1 (0.2%) patient having a MACE, and 262 (33.7%) patients had an m-HS≥4, with 6 (2.3%) patients having MACEs ( P =0.007). Over 4 to 14 hours, 661 patients had a hs-cTnT<14 ng/L. Of those 661 patients, 413 (62.5%) patients had an m-HS≤3, with 1 (0.2%) patient having a MACE, and 248 (37.5%) patients had an m-HS≥4, with 5 (2.0%) patients having MACEs ( P =0.03). Conclusions—: Serial testing of hs-cTnT over 1 hour along with application of an m-HS identified a low-risk population that might be able to be directly discharged from the emergency department.

1 September 2003 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
JMJames McCord
James McCord
RNRichard M. Nowak
Richard M. Nowak
MHMichael P. Hudson
Michael P. Hudson
PMPeter A. McCullough
Peter A. McCullough
MTMichael C. Tomlanovich
Michael C. Tomlanovich
WWW.DOuglas Weaver
W.DOuglas Weaver

1 February 2019 in International Journal of Cardiology
Verified
Journal Article
Closed access
MMMatthias Mueller-Hennessen
Matthias Mueller-Hennessen
BLBertil Lindahl
Bertil Lindahl
EGEvangelos Giannitsis
Evangelos Giannitsis
MVMehrshad Vafaie
Mehrshad Vafaie
MBMoritz Biener
Moritz Biener
CMChristian Mueller
Christian Mueller

1 October 2018 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
RNRichard M. Nowak
Richard M. Nowak
GJGordon Jacobsen
Gordon Jacobsen
RCRobert H. Christenson
Robert H. Christenson
MMMichele Moyer
Michele Moyer
MHMichael P Hudson
Michael P Hudson
JMJames McCord
James McCord

15 June 2024 in Annals of Emergency Medicine
Verified
Journal Article
Open access
JMJoseph Miller
Joseph Miller
BCBernard Cook
Bernard Cook
CGChaun Gandolfo
Chaun Gandolfo
NMNicholas L. Mills
Nicholas L. Mills
SMSimon Mahler
Simon Mahler
JMJames McCord
James McCord
The real-world effectiveness and safety of a 0/1-hour accelerated protocol using high-sensitivity cardiac troponin (hs-cTn) to exclude myocardial infarction (MI) compared to routine care in the United States is uncertain. The objective was to compare a 0/1-hour accelerated protocol for evaluation of MI to a 0/3-hour standard care protocol. The RACE-IT trial was a stepped-wedge, randomized trial across 9 emergency departments (EDs) that enrolled 32,609 patients evaluated for possible MI from July 2020 through April 2021. Patients undergoing high-sensitivity cardiac troponin I testing with concentrations less than or equal to 99th percentile were included. Patients who had MI excluded by the 0/1-hour protocol could be discharged from the ED. Patients in the standard care protocol had 0- and 3-hour troponin testing and application of a modified HEART score to be eligible for discharge. The primary endpoint was the proportion of patients discharged from the ED without 30-day death or MI. There were 13,505 and 19,104 patients evaluated in the standard care and accelerated protocol groups, respectively, of whom 19,152 (58.7%) were discharged directly from the ED. There was no significant difference in safe discharges between standard care and the accelerated protocol (59.5% vs 57.8%; adjusted odds ratio (aOR)=1.05, 95% confidence interval [CI] 0.95 to 1.16). At 30 days, there were 90 deaths or MIs with 38 (0.4%) in the standard care group and 52 (0.4%) in the accelerated protocol group (aOR=0.84, 95% CI 0.43 to 1.68). A 0/1-hour accelerated protocol using high-sensitivity cardiac troponin I did not lead to more safe ED discharges compared with standard care.